David Hallal
Director; Director, Chief Executive Officer · 4 filings · Latest: Sep 21, 2026
Kalaris Therapeutics, Inc.
Scholar Rock Holding Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SRRK | David Hallal | Director, Chief Executive Officer | Apr 16, 2026 | Sale | $49.57 | 30,615 | $1.5M | 1,639,034 | |
— | DAVID L HALLAL | — | Jun 6, 2025 | Proposed Sale | $10.24 | 38,228 | $391.5K | — | |
— | DAVID L HALLAL | — | Jun 5, 2025 | Proposed Sale | $10.15 | 38,227 | $388.1K | — | |
— | DAVID L HALLAL | — | Jun 4, 2025 | Proposed Sale | $10.07 | 38,227 | $384.8K | — |